Compare
Gilead Sciences vs TG Therapeutics (GILD vs TGTX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Gilead Sciences (GILD) returned +36.1% and TG Therapeutics (TGTX) +75.8%; so far this year the figures are +36.0% and +100.7%.
Gilead Sciences is the larger company by market value, about 22.6 times the size of TG Therapeutics.
Revenue grew +6.5% at GILD and +76.1% at TGTX over the last year.
GILD yields 1.95%. TGTX pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| GILD | TGTX | |
|---|---|---|
| Price | $166.89 | $59.83 |
| 1-day | -0.41% | +3.18% |
| YTD | +35.97% | +100.69% |
| 1 year | +36.15% | +75.75% |
| 3 years | +108.12% | +491.16% |
| Market cap | $207.0B | $9.2B |
| P/E | — | 21.8 |
| P/S | 6.68 | 11.45 |
| P/B | 15.87 | 15.16 |
| Revenue growth | +6.50% | +76.10% |
| EPS growth | -149.00% | +643.20% |
| Gross margin % | 79.9 | 82.4 |
| Net margin % | -12.5 | 55.2 |
| ROE % | -29.6 | 73.1 |
| Debt / equity | 2.01 | 1.23 |
| FCF yield % | 6.7 | 0.2 |
| Dividend yield % | 1.95 | — |
| Beta | 0.37 | 0.56 |
| RSI (14) | 60.2 | 58.7 |
| Technical rating |